Overview

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Status:
Completed
Trial end date:
2015-11-26
Target enrollment:
Participant gender:
Summary
To investigate the potential antiepileptic effects of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
GW Research Ltd
Treatments:
Cannabidiol